Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need - FDA approval paves the way for the ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

"In our opinion, it's the best tool yet in helping end the HIV epidemic for everyone, everywhere." Others agree. In 2024, Science hailed lenacapavir as its "Breakthrough of the Year" in 2024.

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.